Latest Updates

  • CMS Proposes Regulation to Reform DIR fees

    Jan 10, 2022
    On January 6, CMS issued a proposed rule that would reduce unpredictability for pharmacies created by PBMs and health plans taking post point of sale “clawbacks” of uncertain amounts up to several months after the pharmacy counter transactions.
    Full story
  • Positive news on DIR fee reform

    Dec 17, 2021
    CMS Administrator Brooks-LaSure committed that CMS will use its regulatory authority to address DIR post-claim-adjudication fees imposed by PBMs upon pharmacies and providers.
    Full story
  • Act Now to Urge for DIR Fee Reform

    Dec 09, 2021
    Join thousands of other pharmacists by contacting your senators today to urge them to include comprehensive DIR fee reform in the Build Back Better bill! Details below and available on NCPA’s website.
    Full story
  • PBMs Scrutinized in “Forum” by House Oversight and Reform Committee Republicans

    Dec 06, 2021
    Republicans on the U.S. House Committee on Oversight and Reform recently held a 2.5 hour “Forum” on the role of PBMs in pharmaceutical markets in which they clearly signaled that they find political and policy advantages in pressing the issue should they take the majority in the November 2022 elections. All the Republican Representatives and 6 of the 7 witnesses were critical of the role and activities of PBMs.
    Full story
  • Long Term Care (LTC) Pharmacy Definition Act Introduced in the House

    Oct 26, 2021
    On October 15th, Representatives Kurt Schrader (D-OR) and Markwayne Mullin (R-OK) introduced the LTC Pharmacy Definition Act of 2021 in the House of Representatives. This legislation complements the bipartisan Senate version, which was introduced earlier this year.
    Full story